Ad is loading...
GLNLX
Price
$22.88
Change
-$0.19 (-0.82%)
Updated
Nov 15 closing price
RSLDX
Price
$69.58
Change
-$0.86 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

GLNLX vs RSLDX

Header iconGLNLX vs RSLDX Comparison
Open Charts GLNLX vs RSLDXBanner chart's image
MFS Global New Discovery R3
Price$22.88
Change-$0.19 (-0.82%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R5E
Price$69.58
Change-$0.86 (-1.22%)
VolumeN/A
CapitalizationN/A
GLNLX vs RSLDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GLNLX vs. RSLDX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLNLX is a Buy and RSLDX is a Buy.

FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 74.7B vs. GLNLX (76M). RSLDX pays higher dividends than GLNLX: RSLDX (0.83) vs GLNLX (0.00). GLNLX was incepted earlier than RSLDX: GLNLX (13 years) vs RSLDX (9 years). GLNLX (29.00) and RSLDX (29.00) have comparable annual turnover. GLNLX has a lower initial minimum investment than RSLDX: GLNLX (0) vs RSLDX (250). RSLDX annual gain was more profitable for investors over the last year : 16.23 vs. GLNLX (15.38). RSLDX return over 5 years is better than : 20.19 vs. GLNLX (13.94).
GLNLXRSLDXGLNLX / RSLDX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD5.2443.928133%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets76M74.7B0%
Annual Yield % from dividends0.000.83-
Returns for 1 year15.3816.2395%
Returns for 3 years-16.59-25.4265%
Returns for 5 years13.9420.1969%
Returns for 10 years53.88N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSA43.130.80
+1.89%
National Storage Affiliates Trust
CISS1.110.02
+1.83%
C3is
UTI19.610.07
+0.36%
Universal Technical Institute
TXT84.91-1.19
-1.38%
Textron
HRTX1.19-0.05
-4.03%
Heron Therapeutics